News:Research and scientific results

The study strengthens the validity of blood-based biomarkers for detecting Alzheimer’s disease and other dementias in diverse population settings, representing a key step towards more accessible and equitable diagnosis

This research describes new mechanisms linking the locus coeruleus to deep sleep and reveals differences according to sex and cerebral vascular status.

The study analysed 1147 lumbar punctures performed on 724 participants in the ALFA study

The book is leading reference on biomarkers shaping diagnosis, prognosis, and therapy development in Alzheimer’s disease and related dementias.

These findings reinforce the robustness of current CSF tools for early detection while encouraging sex-aware interpretation when tracking disease biology over time

The international study shows that this biomarker allows detection of the presence of amyloid beta deposits, a key pathology in the development of the disease, in individuals without cognitive impairment

A clinical trial conducted jointly by the Research Institute of Hospital del Mar and the Barcelonaβeta Brain Research Center, concludes that combining a healthy lifestyle program with epigallocatechin gallate (EGCG), a natural compound found in green tea, could offer sustained cognitive benefits in people at high risk of developing Alzheimer’s dise

This research achieved a more precise measurement of sleep quality thanks to the combined use of actigraphy, brain MRI scans, and biomarker analysis.

The international consortium has analyzed almost 40,000 biological samples to identify biomarkers in Alzheimer’s, Parkinson’s, ALS, and other neurodegenerative diseases.